ImmunityBio, Inc. , a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA) has authorized an expanded access program (EAP) that will bring a vital alternative ...
GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Miguel Muniz discussing outcomes for 177 Lu-PSMA-617 with and without concurrent use of androgen receptor pathway ...
Berlin, Germany, February 13, 2025 – Data from the first-in-human radioligand-therapy for muscle invasive bladder cancer (MIBC) using Pentixapharm's Lu177-PentixaTher compound will be shown at the ...
ConferenceFirst-In-Human Data about the Treatment of Muscle-Invasive Bladder Cancer with Pentixapharm’s Lu177-PentixaTher to be Presented at ASCO-GU 2025 13.02.2025 / 14:10 CET/CESTThe issuer is ...
ASCO Genitourinary Cancers Symposium approaches, several highly anticipated studies are set to shape the future of treatment ...
"The scale and scope of data to be presented at the ASCO GU meeting underscore the impact our whole-transcriptome-based Decipher tests are having in treating patients with urologic cancers, and how ...
EXCLUSIVE: Former adult actress Emily Willis has been left 'permanently disabled' after checking into rehab for her ketamine ...
With the paucity of research on effective interventions for DC, research-based guidelines cannot be delineated. Nurses play a key role in assisting older adult clients in identifying and ...
The oxytocin receptor (OXTR) is a G protein-coupled receptor with a diverse repertoire of intracellular signaling pathways, which are activated in response to binding oxytocin (OXT) and a similar ...
Assessment of the older diabetic individual with symptoms of bladder dysfunction includes identification of age-related changes and risk factors arising from physiologic, psychosocial, and ...
IBS and bladder problems may be linked according to research. Bladder issues, like frequent urination, are commonly diagnosed in addition to irritable bowel syndrome (IBS). The overlap between bladder ...